Data Science Funding Announcements & Notices

Data science and informatics funding announcements and notices are available from NCI and NIH programs. Browse below for opportunities, requests for information, notices, and initiatives.

Title FOA Organization Release Date Expire Date Purpose
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) PAR-19-275 NCI This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and… More
National Cancer Institute (NCI) Request for Information (RFI): Strategies for Matching Patients to Clinical Trials NOT-CA-18-063 NCI N/A National Cancer Institute NCI) Request Information RFI): Strategies Matching Patients Clinical Trials Notice Number: NOT-CA-18-063 Key Dates Release Date: April 11, 2018 Related Announcements None… More
Notice of National Cancer Institute (NCI) Participation in PAR-20-100 Genomic Community Resources (U24 Clinical Trial Not Allowed) NOT-CA-20-027 NCI N/A Notice National Cancer Institute NCI) Participation PAR-20-100 Genomic Community Resources U24 Clinical Trial Allowed)” Notice Number: NOT-CA-20-027 Key Dates Release Date: January 28, 2020 Related… More
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed) RFA-CA-22-001 NCI This Funding Opportunity Announcement (FOA) solicits grant applications proposing exploratory research projects focused on the early-stage development of highly innovative technologies offering novel… More
NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) PAR-21-296 NCI This Funding Opportunity Announcement (FOA) is a continuation of the NCI Mentored Research Scientist Development Award to Promote Diversity (K01) to enhance the diversity of thought in the NCI-funded… More
U.S. and Low- and Middle-Income Country (LMIC) HIV-Associated Malignancy Research Centers (U54 Clinical Trial Optional) RFA-CA-22-011 NCI The purpose of this Funding Opportunity Announcement (FOA) is to support research on human immunodeficiency virus (HIV)-associated cancers in low- and middle-income countries (LMICs) through the… More
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) PAR-21-294 NCI The purpose of this Funding Opportunity Announcement (FOA) is to invite research grant applications (R01) for the development and use of current and emerging molecular imaging methods to gain… More
Innovative Research in Cancer Nanotechnology (IRCN) (R01 Clinical Trial Not Allowed) PAR-20-284 NCI This Funding Opportunity Announcement (FOA) entitled "Innovative Research in Cancer Nanotechnology (IRCN)" encourages applications promoting transformative discoveries in cancer biology and… More
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed) PAR-22-090 NCI The purpose of this engineering-oriented funding opportunity announcement (FOA) is to encourage submissions of exploratory/developmental Bioengineering Research Grant (EBRG) applications to… More
Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional) PAR-19-350 NCI Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) announces its interest in supporting meritorious research projects in three distinct domains related to cancer… More
Vote below about this page’s helpfulness.

Enter the characters shown in the image.